MedTrace Logo

Resistance Under the Microscope

NCT01441843 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2023-09-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether lorazepam, which is used to lower preoperative anxiety, also improves postoperative recovery.

This study data will also be used for further research aiming to identify vulnerable patients in the day-case surgery setting.

Conditions

Interventions

DRUG

Lorazepam

Once 1mg \<75kg body weight, 1.5mg 75kg and \>75kg body weight, IV, before surgery

DRUG

NaCl 0.9% (Sodium Chloride)

Once 1ml \<75kg body weight, 1.5ml 75kg or \>75kg body weight, IV, before surgery

Sponsors & Collaborators

Principal Investigators

  • Markus Klimek, MD, PhD · Erasmus Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01441843 on ClinicalTrials.gov